交易 Editas Medicine - EDIT CFD
新增到我的最愛- 摘要
- 曆史數據
- 活動
- 盈虧控制
- 資産負債表
- 現金流
交易條件
價差 | 0.06 | ||||||||
多頭倉位隔夜費用
多頭隔夜費用
前往平台 | -0.026179% | ||||||||
空頭倉位隔夜費用
空頭隔夜費用
前往平台 | 0.003957% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
Editas Medicine Inc ESG Risk Ratings
High Medium Low Negligible
“C”分數表示在公開報告重大 ESG 數據方面令人滿意的相對 ESG 表現和適度的透明度。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 拋售 | 自訂 | 變化 (%) | 打開 | 最高 | 最小 |
---|---|---|---|---|---|---|
Mar 27, 2024 | 7.40 | 0.13 | 1.79% | 7.27 | 7.50 | 7.15 |
Mar 26, 2024 | 7.17 | -0.21 | -2.85% | 7.38 | 7.54 | 7.17 |
Mar 25, 2024 | 7.32 | -0.08 | -1.08% | 7.40 | 7.57 | 7.29 |
Mar 22, 2024 | 7.43 | -0.25 | -3.26% | 7.68 | 7.68 | 7.42 |
Mar 21, 2024 | 7.79 | -0.15 | -1.89% | 7.94 | 8.41 | 7.76 |
Mar 20, 2024 | 7.90 | 0.31 | 4.08% | 7.59 | 8.09 | 7.53 |
Mar 19, 2024 | 7.71 | 0.12 | 1.58% | 7.59 | 7.94 | 7.56 |
Mar 18, 2024 | 7.68 | -0.30 | -3.76% | 7.98 | 8.09 | 7.67 |
Mar 15, 2024 | 8.10 | 0.12 | 1.50% | 7.98 | 8.27 | 7.98 |
Mar 14, 2024 | 8.12 | -0.25 | -2.99% | 8.37 | 8.56 | 8.04 |
Mar 13, 2024 | 8.55 | 0.12 | 1.42% | 8.43 | 8.83 | 8.43 |
Mar 12, 2024 | 8.57 | -0.27 | -3.05% | 8.84 | 9.01 | 8.56 |
Mar 11, 2024 | 8.97 | -0.03 | -0.33% | 9.00 | 9.56 | 8.88 |
Mar 8, 2024 | 9.13 | 0.40 | 4.58% | 8.73 | 9.31 | 8.73 |
Mar 7, 2024 | 8.80 | -0.30 | -3.30% | 9.10 | 9.32 | 8.65 |
Mar 6, 2024 | 9.06 | -0.09 | -0.98% | 9.15 | 9.35 | 8.91 |
Mar 5, 2024 | 9.09 | -0.52 | -5.41% | 9.61 | 9.89 | 9.02 |
Mar 4, 2024 | 9.88 | -0.67 | -6.35% | 10.55 | 10.59 | 9.73 |
Mar 1, 2024 | 10.49 | 0.42 | 4.17% | 10.07 | 11.03 | 9.91 |
Feb 29, 2024 | 10.02 | -1.09 | -9.81% | 11.11 | 11.32 | 9.98 |
Editas Medicine Events
時間 (UTC) | 國家 | 事件 |
---|---|---|
Friday, May 3, 2024 | ||
時間 (UTC) 12:30 | 國家 US
| 事件 Q1 2024 Editas Medicine Inc Earnings Release Q1 2024 Editas Medicine Inc Earnings ReleaseForecast(預報) -返回 - |
Friday, May 31, 2024 | ||
時間 (UTC) 12:30 | 國家 US
| 事件 Editas Medicine Inc Annual Shareholders Meeting Editas Medicine Inc Annual Shareholders MeetingForecast(預報) -返回 - |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 19.712 | 25.544 | 90.732 | 20.531 | 31.937 |
收入 | 19.712 | 25.544 | 90.732 | 20.531 | 31.937 |
總營業費用 | 245.662 | 218.69 | 225.572 | 161.453 | 145.664 |
銷售/一般/行政費用,總計 | 70.704 | 76.183 | 67.576 | 64.555 | 55.01 |
研究與開發 | 174.958 | 142.507 | 157.996 | 96.898 | 90.654 |
營業收入 | -225.95 | -193.146 | -134.84 | -140.922 | -113.727 |
利息收入(費用),非經營淨值 | 4.225 | 2.342 | 2.605 | 7.313 | 3.445 |
其他,淨值 | 1.293 | -1.698 | 16.259 | -0.137 | 0.328 |
稅前淨收入 | -220.432 | -192.502 | -115.976 | -133.746 | -109.954 |
稅後淨收入 | -220.432 | -192.502 | -115.976 | -133.746 | -109.954 |
未計算非常項目前的淨收益 | -220.432 | -192.502 | -115.976 | -133.746 | -109.954 |
淨收入 | -220.432 | -192.502 | -115.976 | -133.746 | -109.954 |
Total Adjustments to Net Income | 0 | ||||
普通股股東可獲收益 (不含非經常性項目) | -220.432 | -192.502 | -115.976 | -133.746 | -109.954 |
普通股股東可獲收益 (含非經常性項目) | -220.432 | -192.502 | -115.976 | -133.746 | -109.954 |
攤薄淨收入 | -220.432 | -192.502 | -115.976 | -133.746 | -109.954 |
攤薄後加權平均股 | 68.6648 | 67.6194 | 58.6094 | 49.9833 | 47.0977 |
扣除特別項目的每股攤薄盈利 | -3.21026 | -2.84685 | -1.9788 | -2.67581 | -2.33459 |
每股正常攤薄盈利 | -3.21026 | -2.84685 | -1.9788 | -2.67581 | -2.33459 |
非常規項目總計 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 2.887 | 9.851 | 6.536 | 0.042 | 6.362 |
收入 | 2.887 | 9.851 | 6.536 | 0.042 | 6.362 |
總營業費用 | 46.981 | 60.812 | 69.982 | 57.562 | 60.596 |
銷售/一般/行政費用,總計 | 17.202 | 23.008 | 17.984 | 16.236 | 16.937 |
研究與開發 | 29.779 | 37.804 | 51.998 | 41.326 | 43.659 |
營業收入 | -44.094 | -50.961 | -63.446 | -57.52 | -54.234 |
利息收入(費用),非經營淨值 | 3.811 | 3.509 | 1.419 | 1.793 | 0.546 |
其他,淨值 | -0.007 | -1.584 | 1.289 | 0.001 | 0.235 |
稅前淨收入 | -40.29 | -49.036 | -60.738 | -55.726 | -53.453 |
稅後淨收入 | -40.29 | -49.036 | -60.738 | -55.726 | -53.453 |
未計算非常項目前的淨收益 | -40.29 | -49.036 | -60.738 | -55.726 | -53.453 |
淨收入 | -40.29 | -49.036 | -60.738 | -55.726 | -53.453 |
普通股股東可獲收益 (不含非經常性項目) | -40.29 | -49.036 | -60.738 | -55.726 | -53.453 |
普通股股東可獲收益 (含非經常性項目) | -40.29 | -49.036 | -60.738 | -55.726 | -53.453 |
攤薄淨收入 | -40.29 | -49.036 | -60.738 | -55.726 | -53.453 |
攤薄後加權平均股 | 71.3767 | 68.9242 | 68.7946 | 68.7361 | 68.6409 |
扣除特別項目的每股攤薄盈利 | -0.56447 | -0.71145 | -0.88289 | -0.81072 | -0.77873 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.56447 | -0.71145 | -0.88289 | -0.81072 | -0.77873 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 356.754 | 507.31 | 419.087 | 463.844 | 374.776 |
現金和短期投資 | 344.274 | 499.845 | 402.11 | 457.14 | 368.955 |
現金等價物 | 141.522 | 203.519 | 139.682 | 238.183 | 134.776 |
應收賬款總額,淨額 | 5.145 | 0.267 | 6.048 | 0.418 | 0.03 |
應收賬款 - 貿易,淨額 | 5.145 | 0.267 | 6.048 | 0.418 | 0.03 |
預付的費用 | 7.335 | 7.198 | 10.929 | 6.286 | 2.918 |
其他流動資産,總計 | 2.873 | ||||
總資産 | 514.321 | 677.483 | 572.602 | 508.885 | 420.386 |
物業/廠房/設備,總計 - 淨額 | 59.217 | 43.291 | 39.148 | 39.648 | 40.232 |
物業/廠房/設備,總計 - 總額 | 80.743 | 58.798 | 50.243 | 46.852 | 47.365 |
累計折舊,總計 | -21.526 | -15.507 | -11.095 | -7.204 | -7.133 |
其他長期資産,總計 | 5.253 | 6.811 | 4.703 | 5.393 | 5.378 |
流動負債總額 | 60.11 | 46.884 | 58.208 | 59.963 | 35.9 |
應付賬款 | 9.511 | 5.05 | 6.408 | 5.843 | 5.327 |
預提費用 | 42.378 | 30.501 | 30.857 | 27.924 | 12.813 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 8.221 | 11.333 | 20.943 | 26.196 | 17.76 |
負債總額 | 153.641 | 123.841 | 179.016 | 246.448 | 184.224 |
長期債務總額 | 0 | 0 | 0 | 0 | 32.417 |
資本租賃義務 | 0 | 32.417 | |||
其他負債,總計 | 93.531 | 76.957 | 120.808 | 186.485 | 115.907 |
股權 | 360.68 | 553.642 | 393.586 | 262.437 | 236.162 |
Redeemable Preferred Stock | 0 | 0 | |||
普通股 | 0.007 | 0.007 | 0.006 | 0.005 | 0.005 |
額外實收資本 | 1442.41 | 1411.83 | 1058.82 | 811.546 | 652.464 |
留存收益(累計赤字) | -1078.13 | -857.699 | -665.197 | -549.221 | -416.278 |
總負債和股東權益 | 514.321 | 677.483 | 572.602 | 508.885 | 420.386 |
已發行普通股總數 | 68.8474 | 68.4353 | 62.5635 | 54.5538 | 48.7589 |
短期投資 | 202.752 | 296.326 | 262.428 | 218.957 | 234.179 |
其他權益,總計 | -3.601 | -0.493 | -0.046 | 0.107 | -0.029 |
長期投資 | 93.097 | 120.071 | 109.664 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 358.603 | 440.978 | 324.458 | 356.754 | 426.629 |
現金和短期投資 | 349.617 | 431.968 | 318.439 | 344.274 | 419.617 |
現金等價物 | 82.537 | 220.817 | 129.021 | 141.522 | 210.704 |
短期投資 | 267.08 | 211.151 | 189.418 | 202.752 | 208.913 |
應收賬款總額,淨額 | 2.422 | 2.286 | 0.242 | 5.145 | 0.12 |
應收賬款 - 貿易,淨額 | 2.422 | 2.286 | 0.242 | 5.145 | 0.12 |
預付的費用 | 6.564 | 6.724 | 5.777 | 7.335 | 6.892 |
總資産 | 504.65 | 541.953 | 464.105 | 514.321 | 531.029 |
物業/廠房/設備,總計 - 淨額 | 43.495 | 47.657 | 49.555 | 59.217 | 38.026 |
物業/廠房/設備,總計 - 總額 | 68.501 | 71.149 | 71.514 | 80.743 | 58.145 |
累計折舊,總計 | -25.006 | -23.492 | -21.959 | -21.526 | -20.119 |
長期投資 | 96.797 | 48.065 | 83.339 | 93.097 | 58.844 |
其他長期資産,總計 | 5.755 | 5.253 | 6.753 | 5.253 | 7.53 |
流動負債總額 | 58.603 | 54.513 | 57.155 | 60.11 | 42.289 |
應付賬款 | 10.411 | 8.066 | 9.047 | 9.511 | 6.836 |
預提費用 | 39.971 | 38.226 | 39.887 | 42.378 | 31.232 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 8.221 | 8.221 | 8.221 | 8.221 | 4.221 |
負債總額 | 144.188 | 142.036 | 146.632 | 153.641 | 116.284 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
其他負債,總計 | 85.585 | 87.523 | 89.477 | 93.531 | 73.995 |
股權 | 360.462 | 399.917 | 317.473 | 360.68 | 414.745 |
普通股 | 0.008 | 0.008 | 0.007 | 0.007 | 0.007 |
額外實收資本 | 1574.38 | 1569.65 | 1446.91 | 1442.41 | 1436.42 |
留存收益(累計赤字) | -1212.48 | -1167.46 | -1127.17 | -1078.13 | -1017.39 |
其他權益,總計 | -1.452 | -2.285 | -2.279 | -3.601 | -4.291 |
總負債和股東權益 | 504.65 | 541.953 | 464.105 | 514.321 | 531.029 |
已發行普通股總數 | 81.6688 | 81.6169 | 68.9936 | 68.8474 | 68.7617 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | -220.432 | -192.502 | -115.976 | -133.746 | -109.954 |
經營活動産生的現金 | -177.349 | -163.803 | -179.843 | -40.669 | -45.707 |
經營活動産生的現金 | 6.337 | 5.053 | 3.959 | 2.83 | 3.254 |
非現金物品 | 28.57 | 45.056 | 34.394 | 24.315 | 34.105 |
已付現金利息 | |||||
營運資金的變化 | 8.176 | -21.41 | -102.22 | 65.932 | 26.888 |
投資活動産生的現金 | 114.068 | -54.466 | -140.522 | 12.252 | -53.087 |
資本支出 | -4.118 | -7.977 | -7.162 | -6.167 | -4.754 |
其他投資現金流量項目,總計 | 118.186 | -46.489 | -133.36 | 18.419 | -48.333 |
融資活動産生的現金 | 1.284 | 282.106 | 224.122 | 131.824 | 86.94 |
融資現金流項目 | |||||
股票的發行(報廢),淨額 | 1.284 | 282.106 | 224.122 | 131.824 | 87.797 |
債務的發行(退還),淨額 | 0 | -0.857 | |||
現金淨變化 | -61.997 | 63.837 | -96.243 | 103.407 | -11.854 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -49.036 | -220.432 | -159.694 | -103.968 | -50.515 |
Cash From Operating Activities | -35.768 | -177.349 | -135.076 | -87.072 | -49.227 |
Cash From Operating Activities | 1.544 | 6.337 | 4.76 | 3.156 | 1.558 |
Non-Cash Items | 5.397 | 28.57 | 23.704 | 18.106 | 11.665 |
Changes in Working Capital | 6.327 | 8.176 | -3.846 | -4.366 | -11.935 |
Cash From Investing Activities | 23.267 | 114.068 | 141.596 | 52.369 | 56.371 |
Capital Expenditures | -1.84 | -4.118 | -3.494 | -2.88 | -2.248 |
Other Investing Cash Flow Items, Total | 25.107 | 118.186 | 145.09 | 55.249 | 58.619 |
Cash From Financing Activities | 0 | 1.284 | 0.665 | 0.585 | 0.218 |
Issuance (Retirement) of Stock, Net | 0 | 1.284 | 0.665 | 0.585 | 0.218 |
Net Change in Cash | -12.501 | -61.997 | 7.185 | -34.118 | 7.362 |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
交易
交易規模(槓桿 x 投資):
打開
拋售
已賣出 做多
Industry: | Biotechnology & Medical Research (NEC) |
11 Hurley St
CAMBRIDGE
MASSACHUSETTS 02141-2110
US
盈虧控制
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 580.000 多名交易者,選擇與 Capital.com 交易